Nkarta, Inc. (NKTX)
NASDAQ: NKTX · Real-Time Price · USD
1.855
-0.145 (-7.25%)
Mar 31, 2025, 1:31 PM EDT - Market open
Nkarta Employees
Nkarta had 150 employees as of December 31, 2023. The number of employees decreased by 13 or -7.98% compared to the previous year.
Employees
150
Change (1Y)
-13
Growth (1Y)
-7.98%
Revenue / Employee
n/a
Profits / Employee
-$725,267
Market Cap
131.63M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 150 | -13 | -7.98% |
Dec 31, 2022 | 163 | 27 | 19.85% |
Dec 31, 2021 | 136 | 41 | 43.16% |
Dec 31, 2020 | 95 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
NKTX News
- 2 hours ago - Nkarta: Grinding Lower, Trying To Find Support - Seeking Alpha
- 3 hours ago - Nkarta: Betting On The Turnaround - Seeking Alpha
- 4 days ago - Why Is Autoimmune Disease Focused Nkarta Stock Trading Higher On Thursday? - Benzinga
- 4 days ago - Nkarta Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights - GlobeNewsWire
- 4 weeks ago - Nkarta to Participate in March Investor Conferences - GlobeNewsWire
- 4 months ago - Nkarta Announces IND Clearance of Investigator-Sponsored Trial in Myasthenia Gravis and Opening of Enrollment for Ntrust-2 - GlobeNewsWire
- 4 months ago - Nkarta to Participate in an Upcoming Investor Conference - GlobeNewsWire
- 5 months ago - Nkarta Reports Third Quarter 2024 Financial Results and Corporate Highlights - GlobeNewsWire